Michael Winkelmann
Impact in
-
- Viral Infections and Vectors
- Infectious Encephalopathies and Encephalitis
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 23
- CAR-T cell therapy research 14
- Lung Cancer Research Studies 7
-
- Neuroblastoma Research and Treatments 5
- Co-authors
- Wolfgang G. Kunz (20 shared papers)Maryam B. Haddad (1 shared paper)Anthony A. Marfin (1 shared paper)A. Arturo Leis (1 shared paper)James J. Sejvar (1 shared paper)Dobrivoje S. Stokić (1 shared paper)Lyle R. Petersen (1 shared paper)Sally Slavinski (1 shared paper)
- Journals
- European Radiology (5 papers)Cancer Imaging (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Blood (3 papers)Frontiers in Oncology (2 papers)
- Partner nations
- GermanyUnited StatesSlovakia
In The Last Decade
Michael Winkelmann
33 papers receiving 364 citations
Peers
Comparison fields: 5 of 65
- Infectious Diseases 98
- Oncology 126
- Public Health, Environmental and Occupational Health 111
- Immunology and Allergy 14
- Neurology 34
Countries citing papers authored by Michael Winkelmann
This map shows the geographic impact of Michael Winkelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Winkelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Winkelmann more than expected).
Fields of papers citing papers by Michael Winkelmann
This network shows the impact of papers produced by Michael Winkelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Winkelmann. The network helps show where Michael Winkelmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Winkelmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 125 | |
| 2 | 2014 | 61 | |
| 3 | 2020 | 36 | |
| 4 | 2022 | 24 | |
| 5 | 2023 | 20 | |
| 6 | 2022 | 12 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2000 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 4 | |
| 19 | Aktienbewertung in Deutschland | 1984 | 3 |
| 20 | 2007 | 3 |
About Michael Winkelmann
Michael Winkelmann is a scholar working on Oncology, Neurology, Epidemiology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 372 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Lung Cancer Research Studies (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Integrated Circuits and Semiconductor Failure Analysis (5 papers), Neuroblastoma Research and Treatments (5 papers), Medical Imaging Techniques and Applications (3 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Infectious Diseases (98 citations), Oncology (126 citations), Public Health, Environmental and Occupational Health (111 citations), Immunology and Allergy (14 citations) and Neurology (34 citations). Michael Winkelmann has collaborated with scholars based in Germany, United States and Slovakia. Frequent co-authors include Wolfgang G. Kunz, Maryam B. Haddad, Anthony A. Marfin, A. Arturo Leis, James J. Sejvar, Dobrivoje S. Stokić, Lyle R. Petersen, Sally Slavinski, Jay A. van Gerpen and Bruce C. Tierney. Their work appears in journals such as European Radiology, Cancer Imaging, European Journal of Nuclear Medicine and Molecular Imaging, Blood and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.